Nuclear receptor agonists

Nuclear receptor agonists has been studied in 1 paper since 2023: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Mar 13, 2023: “A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on nuclear receptor agonists

At a glance

The findings reach cells, none yet in people. 1 lab.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 1 lab
  • Funders: National Center for Advancing Translational Sciences and 3 more
  • Cells1

What did studies of nuclear receptor agonists find?

1

Studies of nuclear receptor agonists measured one outcome, impaired microbial clearance.

Impaired microbial clearance

downin human cells1

1 study
  1. Nuclear receptor agonists decrease impaired microbial clearance in immune-deficient infectious Crohn's disease patient-derived organoids (IDICD).

    “impaired microbial clearance in IDICD was reversed using agonists for nuclear receptors”

    Cellsin immune-deficient infectious Crohn's disease patient-derived organoids (IDICD)colonic epithelium

    A Living Organoid Biobank of Crohn's Disease Patients Reveals Molecular Subtypes for Personalized Therapeutics

    bioRxiv : the preprint server for biologyPreprint

Latest